Space is limited, please sign up today!
In this exclusive webinar, BioCentury and BioKatalyst bring together industry and health leaders to discuss how biotech leaders can accelerate COVID-19 product development.
The global COVID-19 crisis has set off a race to develop medical countermeasures that is mobilizing researchers in China, the U.S. and Europe to develop therapies, vaccines, and diagnostics at an unprecedented pace. This contest will serve as an experiment to test competing scientific, technological, and regulatory approaches for rapidly responding to outbreaks of emerging infectious diseases. In this exclusive webinar, BioCentury and BioKatalyst bring together industry and health leaders to discuss how biotech leaders can accelerate COVID-19 product development.
Registration is required: Register
BioCentury is a global business intelligence company serving the biopharmaceutical industry and investors.
Access the latest publications from here: https://www.biocentury.com
This webinar is hosted and produced by BioCentury and BioKatalyst. Any question about the webinar, please contact BioCentury at biocentury@biocentury.com
Please contact the library at markuslibrary@rockefeller.edu for any comments and question.